Literature DB >> 30100380

Treatment of platinum refractory or resistant ovarian cancer.

Gabriella Ferrandina1, Giacomo Corrado2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30100380     DOI： 10.1016/S1470-2045(18)30428-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Comprehensive network analysis of dysregulated genes revealed MNX1-AS1/hsa-miR-4697-3p/HOXB13 axis in ovarian cancer chemotherapy response.

Authors:  Anqi Wu; Jiaqi Liu; Xiaojun Zhang; Chenxi Niu; Guang Shu; Gang Yin
Journal:  Cancer Sci       Date:  2022-06-24       Impact factor: 6.518

2.  The role of a drug-loaded poly (lactic co-glycolic acid) (PLGA) copolymer stent in the treatment of ovarian cancer.

Authors:  Yanqing Wang; Xiaoyin Qiao; Xiao Yang; Mengqin Yuan; Shu Xian; Li Zhang; Dongyong Yang; Shiyi Liu; Fangfang Dai; Zhikai Tan; Yanxiang Cheng
Journal:  Cancer Biol Med       Date:  2020-02-15       Impact factor: 4.248

3.  Integrative analysis of the common genetic characteristics in ovarian cancer stem cells sorted by multiple approaches.

Authors:  Xiaoxiao Zhang; Yue Su; Xue Wu; Rourou Xiao; Yifan Wu; Bin Yang; Zhen Wang; Lili Guo; Xiaoyan Kang; Changyu Wang
Journal:  J Ovarian Res       Date:  2020-09-25       Impact factor: 4.234
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.